Protalix Biotherapeutics to Present at the UBS Warburg Global Life Sciences Conference

CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (Amex: PLX), announced today that Dr. David Aviezer, President and CEO, will present at the UBS Global Life Sciences Conference on Wednesday, September 24, 2008 at 1:30 PM ET. The conference is being held at the Grand Hyatt Hotel in New York City.

MORE ON THIS TOPIC